What is the mechanism of lacosamide's effect?

Lacosamide’s primary mechanism of action

Lacosamide is an antiepileptic drug that works by stabilizing the slow‑inactivation state of voltage‑gated sodium (Na⁺) channels. Here’s how that helps control seizures:

| Step | What happens | Why it matters |
|------|--------------|----------------|
| 1 | Lacosamide binds to a distinct site on the α‑subunit of the Na⁺ channel (the S3–S4 linker region). | It doesn’t interfere with the usual “fast” inactivation that most sodium‑channel blockers use. |
| 2 | The drug enhances the “slow” inactivation process – the gradual, long‑lasting reduction in Na⁺ channel availability that occurs during prolonged depolarization. | By promoting this state, lacosamide keeps channels “off” for a longer time during sustained activity. |
| 3 | Neuronal firing is dampened because Na⁺ influx is curtailed during periods of high excitability. | Less repetitive firing → fewer seizures. |

Why the slow‑inactivation target is useful

- Selectivity: Fast‑inactivating drugs (e.g., carbamazepine, phenytoin) can affect normal brain and cardiac activity, leading to side‑effects like arrhythmias.
- Clinical benefit: Slow‑inactivation modulation is particularly effective in focal (partial) seizures and Lennox‑Gastaut syndrome, where prolonged neuronal firing is a hallmark.
- Safety: Because lacosamide’s action is limited to the slow‑inactivation phase, it has a lower risk of affecting cardiac Na⁺ channels, resulting in minimal QT‑interval prolongation.

Additional pharmacologic notes

- Protein phosphatase 2A (PP2A): Some data suggest lacosamide may also modulate PP2A activity, potentially influencing neuronal signaling, but this is not considered its primary antiepileptic action.
- Drug interactions: Lacosamide can reduce the plasma concentration of certain antiepileptics (e.g., oxcarbazepine) and may be affected by CYP3A4 inducers/inhibitors.
- Side‑effects: Commonly reported dizziness, ataxia, diplopia, and headache—often linked to its central nervous system effects.

In short – Lacosamide works by “locking” sodium channels in a slow‑inactivated state, thereby reducing abnormal, sustained neuronal firing that underlies seizures. This unique mechanism gives it a useful place in the epilepsy‑drug armamentarium, especially when other sodium‑channel blockers are ineffective or poorly tolerated.